Cat. No.: DIA-0231227
Product Information | |
---|---|
CAS No. | 1469924-27-3 |
Formula | C17H21N3O |
Molecular Weight | 283.37 |
SMILES | CN(C)C(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)N(C)C |
Target | Adipose triglyceride lipase (ATGL) |
Product Description | Atglistatin is a highly potent, and selective inhibitor of adipose triglyceride lipase (ATGL) with IC50 of 0.7 μM, high selectivity over other key metabolic lipases. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.